Ozturk, B. Et Al. 2009. Elevated serum levels of M30 and M65 in patients with locally advanced head and neck tumors. INTERNATIONAL IMMUNOPHARMACOLOGY , vol.9, no.5 , 645-648.

Ozturk, B., Coskun, U., Sancak, B., Yaman, E., Buyukberber, S., & Benekli, M., (2009). Elevated serum levels of M30 and M65 in patients with locally advanced head and neck tumors. INTERNATIONAL IMMUNOPHARMACOLOGY , vol.9, no.5, 645-648.

Ozturk, Banu Et Al. "Elevated serum levels of M30 and M65 in patients with locally advanced head and neck tumors," INTERNATIONAL IMMUNOPHARMACOLOGY , vol.9, no.5, 645-648, 2009

Ozturk, Banu Et Al. "Elevated serum levels of M30 and M65 in patients with locally advanced head and neck tumors." INTERNATIONAL IMMUNOPHARMACOLOGY , vol.9, no.5, pp.645-648, 2009

Ozturk, B. Et Al. (2009) . "Elevated serum levels of M30 and M65 in patients with locally advanced head and neck tumors." INTERNATIONAL IMMUNOPHARMACOLOGY , vol.9, no.5, pp.645-648.

@article{article, author={Banu Ozturk Et Al. }, title={Elevated serum levels of M30 and M65 in patients with locally advanced head and neck tumors}, journal={INTERNATIONAL IMMUNOPHARMACOLOGY}, year=2009, pages={645-648} }